About
ABOUT ASENT 2022
ASENT 2022 is the premier neuroscience and neurotherapeutics conference where senior leaders from leading payers, providers, employers, investors, fast-growing startups, pharma, policymakers, funders and innovation centers gather to ask one question: how can we improve the process of bringing neurotherapeutics to market?
The plenary sessions, panel discussions, outstanding pipeline presentations and poster sessions will focus on the latest science in neurotherapeutics including innovations in rare disease, antisense technology across disease states, novel delivery systems, gene therapy and biomarkers, and of course the latest drug therapies and devices.
WHO ATTENDS
Physician-Scientists | Neurologists | Neuroscientists | Drug and Device Companies | Fellows | Post-docs | Founders | Funders | Industry Leaders | Nonprofit Organizations and Advocacy Groups | Journal Editors | Representatives from NIH, NIA, NIDA, NINDS and FDA
WHAT IS ASENT
The American Society for Experimental Neurotherapeutics (ASENT) is an independent non-profit organization established in 1997 by leaders in academia, government, advocacy, and industry to facilitate the process by which new therapies are made available to patients with neurological disorders. Its primary goal is to encourage and advance the development of improved therapies for diseases and disorders of the nervous system.
JOIN ASENT
If you aren’t yet a member of ASENT, now is the time to do it. Here are a few reasons to join today:
- ASENT members will have access to annual meeting content for 12 months at no additional cost. Nonmembers will pay a fee to view annual meeting content after 7 days following the conference.
- Members receive access to Neurotherapeutics, the official journal of ASENT (Impact Factor: 7.620).
- Membership rates are very reasonable.
Join a community of professionals in industry, government, academia and advocacy working together to bring neurotherapeutics to market.